How To Use HCPCS Code C2623

HCPCS code C2623 describes a specific type of catheter used in transluminal angioplasty procedures. This code is used to identify a drug-coated catheter that is non-laser. In this article, we will explore the details of HCPCS code C2623, including its official description, procedure, when to use it, billing guidelines, historical information, and Medicare and insurance coverage.

1. What is HCPCS C2623?

HCPCS code C2623 is used to identify a specific type of catheter used in transluminal angioplasty procedures. This catheter is drug-coated and does not involve the use of lasers. It is important to use this code accurately to ensure proper documentation and billing for the procedure.

2. Official Description

The official description of HCPCS code C2623 is “Catheter, transluminal angioplasty, drug-coated, non-laser.” The short description for this code is “Parenteral supp not othrws c.” It is crucial to use the exact official description and short description when documenting and billing for this procedure.

3. Procedure

1. The provider begins the procedure by accessing the patient’s blood vessels using a small incision or puncture.
2. A guide wire is then inserted into the blood vessel and advanced to the site of the blockage or narrowing.
3. The drug-coated catheter, identified by HCPCS code C2623, is threaded over the guide wire and positioned at the site of the blockage.
4. The drug-coated catheter is then inflated, which helps to widen the narrowed or blocked blood vessel.
5. Once the desired result is achieved, the catheter is deflated and removed from the patient’s body.
6. The incision or puncture site is then closed, and appropriate post-procedure care is provided to the patient.

4. When to use HCPCS code C2623

HCPCS code C2623 should be used when performing transluminal angioplasty procedures using a drug-coated catheter that does not involve the use of lasers. It is important to accurately document and code the procedure to ensure proper reimbursement and compliance with coding guidelines.

5. Billing Guidelines and Documentation Requirements

When billing for a procedure using HCPCS code C2623, healthcare providers need to ensure proper documentation of the procedure, including the medical necessity and indication for using a drug-coated catheter. Additionally, the provider should include any relevant clinical notes, imaging reports, and other supporting documentation to justify the use of this specific catheter.

6. Historical Information and Code Maintenance

HCPCS code C2623 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. As indicated by the action code N, no maintenance actions have been taken for this code. This means that there have been no updates or revisions to the code since its addition.

7. Medicare and Insurance Coverage

HCPCS code C2623 is eligible for coverage by Medicare and other insurance providers. The pricing indicator code for this code is 57, which indicates that it is priced by other carriers. The multiple pricing indicator code is A, which means that it is not applicable as HCPCS priced under one methodology. Healthcare providers should refer to the Medicare Carriers Manual Reference Section Number 2130 for specific guidelines and instructions regarding coverage and reimbursement for this code.

8. Examples

Here are five examples of when HCPCS code C2623 should be billed:

1. A patient undergoes transluminal angioplasty using a drug-coated catheter to treat a narrowed coronary artery.
2. A physician performs transluminal angioplasty using a drug-coated catheter to address a stenosis in a peripheral artery.
3. A patient with a blocked femoral artery undergoes transluminal angioplasty using a drug-coated catheter.
4. A cardiologist performs transluminal angioplasty using a drug-coated catheter to treat a patient with coronary artery disease.
5. A vascular surgeon uses a drug-coated catheter for transluminal angioplasty to address a blockage in a carotid artery.